Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GlobeImmune finally goes public through $16.6mm IPO

Executive Summary

GlobeImmune Inc. (cancer and infectious disease immunotherapeutics) completed its $16.6mm initial public offering, selling 1.75mm shares (including the overallotment) at $10, well below its intended range in May of $15-17. The company first filed in July 2012 (and had hoped to bring in up to $65mm through that attempt, with a range of 5mm shares for between $11-13), but withdrew in October 2013, before refiling again in March 2014.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies